Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Suit Says Cytodyne Omitted Side Effects From Ephedra-Free Supplement Label

This article was originally published in The Tan Sheet

Executive Summary

The New Jersey Attorney General's Office and the state's Division of Consumer Affairs are seeking to enjoin Cytodyne Technologies from making or disseminating further advertisements that contain unsubstantiated claims about its Xenadrine EFX ephedra-free dietary supplement

You may also be interested in...

Xenadrine Safety Misrepresentations Alleged In Bechler Suit v. Cytodyne

Cytodyne's failure to adequately warn consumers about potential risks from taking ephedra-containing Xenadrine RFA-1 is the basis for a wrongful-death lawsuit filed by Orioles pitcher Steve Bechler's widow, Kiley Bechler, July 16

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts